Delivery Order SPE2DB22D1017-SPE2DB24FF9ZT
Award Date 6/24/24
Potential Completion Date 6/25/24
Potential Value $2.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,930,073 units of the prescription medication Vyvanse 40 mg capsules. The contract has a ceiling value of $1,313.24 and a completion date of June 18, 2024. It was awarded by the Defense Logistics Agency (DLA) on June 17, 2024 as a firm fixed-price delivery order contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the prescription drug Vyvanse 40mg capsules to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract has a ceiling value of $2,422.08 and is a firm fixed-price delivery order, with a period of performance through July 8, 2024. This award is associated with Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,565,122,470 units of the prescription drug Vyvanse 10mg capsules. The contract has a ceiling value of $2,586.00 and a period of performance through July 12, 2024. It was awarded on a firm-fixed price basis by the Defense Logistics Agency (DLA), a defense agency within the Department of Defense. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,565,007,823 units of the drug Vyvanse (30 mg capsules) to the U.S. government. The total ceiling value of the contract is $2,711.54, and it is structured as a Firm Fixed Price Delivery Order. The contract was awarded on June 26, 2024, with a completion date of June 27, 2024. The awarding agency is the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,978,188 units of Vyvanse 40 mg capsules. The $1,567.08 contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a Defense agency, and has a completion date of June 24, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4564375451 - Vyvanse 20mg capsules, 100s, with a ceiling value of $2,243.03. The contract was awarded on April 23, 2024 by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 24, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical...
- This federal contract award to Amerisourcebergen Drug Corp (a major pharmaceutical distributor and healthcare solutions provider) is for the delivery of Vyvanse 30 mg capsules over a period ending on November 4, 2024. The contract, valued at $1,947.26, was awarded by the Defense Logistics Agency (DLA), a defense agency, on November 1, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,565,068,663 units of the pharmaceutical product Vyvanse 60 mg capsules. The $4,187.79 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract has an ultimate completion date of July 5, 2024, and was awarded on July 3, 2024 without any set-aside designation. Amerisourcebergen, a major...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vyvanse 30 mg capsules. The contract has a firm fixed price, ceiling value of $1,121.72, and a completion date of June 21, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...
- This federal contract award is for the delivery of 4,565,099,639 units of the prescription drug Vyvanse (50 mg capsules) to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD). The contract, valued at $2,579.01, was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is a firm fixed-price Delivery Order with a completion date of July 10, 2024. Amerisourcebergen holds several...